Trademark: 79243427
Word
CELLECTIS
Status
Registered
Status Code
700
Status Date
Tuesday, November 24, 2020
Serial Number
79243427
Registration Number
6202570
Registration Date
Tuesday, November 24, 2020
Mark Type
3000
Filing Date
Friday, April 6, 2018
Published for Opposition
Tuesday, September 8, 2020

Trademark Owner History
CELLECTIS - Original Registrant

Classifications
5 Pharmaceutical products for the treatment of cancer, immune system related diseases and disorders; microorganism cultures and nutritive substances for microorganism cultures for medical and pharmaceutical use; bacteriological preparations for medical and pharmaceutical use; biological preparations for medical and pharmaceutical use for treating cancer, immune system or genetic diseases or disorders, and malnutrition; chemical and biochemical preparations for medical, pharmaceutical, and therapeutic use for treating cancer and malnutrition; micro-organism preparations and cultures for medical, pharmaceutical and veterinary purposes; health food, beverages, preparations and substances, namely, dietetic foods for the treatment of celiac disease, nutritional supplements, medical preparations and substances for treatment of malnutrition, cancer, high cholesterol, cardiovascular disease, diabetes, coronary heart disease, immune system related diseases and disorders, nutritionally fortified beverages for medical purposes; plant-based health-food substances, namely, dietetic foods, namely, edible oils and fats, processed fruits and vegetables, preserved, dried and cooked fruits and vegetables, potato based snack food, soybeans based snack food, potato crisps, potato flakes and potato fritters, potato fries, cooked ready meals consisting primarily of vegetables, soya crisps, soya flakes, soya fries, corn-based snack food, wheat based snack foods, oat based snack foods, alfalfa based snack foods, coffee, coffee substitutes, seasonings, sauces and condiments, namely, mustard, ketchup and other tomatoes sauces, cooked ready meals consisting primarily of pasta or rice, potato, soya, corn, wheat, alfalfa or oat based foods, namely, puree, corn, wheat, alfalfa or oat crisps, soya, corn, wheat, alfalfa and oat flour, corn, wheat, alfalfa and oat flakes, corn, wheat, alfalfa and oat fries, adapted for medical use; dietary supplements; nutritional supplements; nutritional additives in the nature of dietary and nutritional supplements for medical purposes; cultures and preparations of micro-organisms for medical or therapeutic, pharmaceutical and veterinary use, namely, human and animal cells in the nature of biological tissue cultures for the treatment of cancer, immune system related diseases and disorders; bacteriological preparations for in vivo and in vitro genetic engineering, for medical, pharmaceutical and veterinary purposes; medicines for veterinary use for treating cancer and malnutrition; medicines for human use for treating cancer and malnutrition; Diagnostic preparations for the treatment of cancer, immune system related diseases and disorders, malnutrition; Pharmaceutical products for medical purposes in the nature of enzymes, namely, natural and engineered nucleases, nucleic acid vectors, molecular scissors; Chemical and pharmaceutical products for medical purposes in the nature of enzymes, namely, natural and engineered nucleases, nucleic acid vectors and molecular scissors; Veterinary products, namely, nucleic acid sequences being enzymes, stem cells, chemical and biological reagents, bacteria, yeasts, enzymes, bacteriological preparations, natural and engineered endoncucleases being enzymes
42 Technical studies and evaluation of new products in the pharmaceutical industry; engineering services; computer programming; Design and development of computer software and hardware; scientific and industrial research in the agri-food, horticulture and agriculture sector for genome modification of cells of all types; genetic, medical and pharmaceutical research; research in chemistry, biology, biochemistry, molecular biology or bacteriology; research and development in biochemical analysis, biological analysis and molecular biology techniques; Research and development of new compounds for use in industry, agriculture and horticulture; scientific laboratory services
The mark consists of the literal element "CELLECTIS" wherein the letters "CE ECTIS" are in dark blue and the "L's" are formed in a combination of dark blue, light blue, and medium blue.
The color(s) dark blue, light blue and medium blue is/are claimed as a feature of the mark.

Trademark Events
Oct 28, 2023
New Representative At Ib Received
Oct 18, 2023
Teas Change Of Correspondence Received
Oct 18, 2023
Teas Change Of Domestic Representatives Address
Oct 18, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 18, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 18, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 18, 2023
Teas Change Of Owner Address Received
Mar 14, 2021
Final Decision Transaction Processed By Ib
Feb 24, 2021
Final Disposition Notice Sent To Ib
Feb 24, 2021
Final Disposition Processed
Feb 24, 2021
Final Disposition Notice Created, To Be Sent To Ib
Nov 24, 2020
Registered-Principal Register
Sep 8, 2020
Official Gazette Publication Confirmation E-Mailed
Sep 8, 2020
Published For Opposition
Sep 5, 2020
Notification Processed By Ib
Aug 19, 2020
Notification Of Possible Opposition Sent To Ib
Aug 19, 2020
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 19, 2020
Notification Of Notice Of Publication E-Mailed
Aug 3, 2020
Approved For Pub - Principal Register
Aug 3, 2020
Teas/Email Correspondence Entered
Aug 3, 2020
Correspondence Received In Law Office
Jul 27, 2020
Assigned To Lie
Jul 24, 2020
Teas Request For Reconsideration Received
Apr 3, 2020
Notification Of Possible Opposition - Processed By Ib
Mar 18, 2020
Notification Of Possible Opposition Sent To Ib
Mar 18, 2020
Notification Of Possible Opposition Created, To Be Sent To Ib
Jan 31, 2020
Notification Of Final Refusal Emailed
Jan 31, 2020
Final Refusal E-Mailed
Jan 31, 2020
Final Refusal Written
Jan 10, 2020
Previous Allowance Count Withdrawn
Jan 10, 2020
Approved For Pub - Principal Register
Dec 13, 2019
Teas/Email Correspondence Entered
Dec 13, 2019
Correspondence Received In Law Office
Dec 11, 2019
Assigned To Lie
Dec 2, 2019
Teas Response To Office Action Received
Jun 28, 2019
Refusal Processed By Ib
May 30, 2019
Non-Final Action Mailed
May 29, 2019
Non-Final Action Written
May 8, 2019
Teas/Email Correspondence Entered
May 7, 2019
Correspondence Received In Law Office
May 7, 2019
Teas Response To Office Action Received
Dec 8, 2018
Refusal Processed By Ib
Nov 16, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Nov 15, 2018
Refusal Processed By Mpu
Oct 31, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Oct 30, 2018
Non-Final Action Written
Oct 27, 2018
Application Filing Receipt Mailed
Oct 23, 2018
Assigned To Examiner
Oct 23, 2018
New Application Office Supplied Data Entered
Oct 18, 2018
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24